Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05833334 · ClinicalTrials.gov registry record · NA
Healthy Homes Study
A NA study of Lung Cancer and Home Air Radon Testing, sponsored by Dartmouth-Hitchcock Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 172
- Enrollment target
- 1
- Study location
NCT05833334: Recruiting NA study of Lung Cancer and Home Air Radon Testing, sponsored by Dartmouth-Hitchcock Medical Center.
NCT05833334 is a NA study of Lung Cancer and Home Air Radon Testing that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 172 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05833334, a NA study of Lung Cancer and Home Air Radon Testing, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 172 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is about home air radon testing and has two phases. The goal of the first phase is to learn about renters' and homeowners' views and plans related to radon testing. The main question this phase aims to answer is: 1\. Does taking part in a focus group with information about radon testing change people's plans to test for radon? Participants in the first study phase will: * Take a survey about their views on and plans for radon testing. * Take part in a focus group discussion about radon testing, during which they will receive information about radon testing. * Right after the focus group, take a survey about their plans for radon testing. The second phase is a pilot interventional study. The goal is to test interventions about radon testing with renters and homeowners who smoke and do not smoke. The main questions this phase aims to answer are: 1. Does the recruitment strategy result in enough participants enrolling within 3 months? 2. Will at least 80% of participants complete data collection activities? 3. Will more participants who view an online intervention developed by the researchers request free radon test kits, set them up in their homes, and complete radon testing, compared to participants who view a standard public health infographic? And will even more participants who receive reminder messages, in addition to the online intervention, request free radon test kits, set them up in their homes, and complete radon testing? Participants in this second phase will: * Take a survey about their views on and plans for radon testing. * View an intervention about radon testing. * Right after viewing the intervention, take a survey about their views on and plans for radon testing. * 2 months later, take a survey about what, if any, steps they've taken to test their homes for radon. * Provide the researchers permission to collect data from their State Radon Program on: a) whether they requested a free radon test kit and b) whether testing was complet
Primary Outcome
Number of participants who consent into the study and meet eligibility criteria within 3 months of study opening to enrollment.
Conditions Studied
Interventions
- BEHAVIORAL Public health infographic (AIM 3)
- BEHAVIORAL Online health promotion intervention tailored by smoking status (AIM 3)
- BEHAVIORAL Online health promotion intervention tailored by smoking status, plus reminder messages (AIM 3)
- BEHAVIORAL Focus group with educational overview (AIM 1)
Study Locations (1)
New Hampshire
- Dartmouth Cancer Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2027-08-24 |
| Phase | NA |
What NCT05833334 shows while recruiting
NCT05833334 is an interventional study that assigns participants to a tested intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (82% lower).
The record links to 2 conditions, with Lung Cancer appearing as the primary indexed condition, and to 4 interventions - of which Public health infographic (AIM 3) is the first listed.
NCT05833334 reports a single indexed study location in New Hampshire.
Frequently Asked Questions
What is clinical trial NCT05833334 about?
NCT05833334 is a clinical study titled "Healthy Homes Study". This study is about home air radon testing and has two phases. The goal of the first phase is to learn about renters' and homeowners' views and plans related to radon testing. The main question this phase aims to answer is: 1\. Does taking part in a focus group with information about radon testing...
What is the current status of trial NCT05833334?
This trial is currently recruiting. It is a NA study. The enrollment target is 172 participants. The study started on 2023-06-01. Estimated completion is 2027-08-24.
What conditions does trial NCT05833334 study?
This clinical trial studies the following conditions: Lung Cancer, Home Air Radon Testing.
What interventions are being tested in trial NCT05833334?
The interventions under investigation include: Public health infographic (AIM 3) (BEHAVIORAL), Online health promotion intervention tailored by smoking status (AIM 3) (BEHAVIORAL), Online health promotion intervention tailored by smoking status, plus reminder messages (AIM 3) (BEHAVIORAL), Focus group with educational overview (AIM 1) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05833334?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05833334 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05833334's enrollment target sits among peer trials
172 138th of 409 higher than 272 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801797 · 172 participants · Phase 2
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
- NCT04867317 · 172 participants · Phase 3
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
- NCT05357040 · 172 participants · Phase 2
Antidepressant Effects of Nitrous Oxide
- NCT05587517 · 172 participants · Phase 2
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI